Combine the Label with Phase III Clinical Results and a Carefully Crafted, Mirroring US Patent Application to Achieve Longer Patent Exclusivity for US Life Science Patents By Michele C. Bosch on December 19, 2018 Email this postTweet this postLike this postShare this post on LinkedIn Federal Circuit Decision: Sanofi v. Watson, 875 F.3d 636 (Fed. Cir. 2017) Read more
